183 related articles for article (PubMed ID: 22050195)
1. Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment.
Lee WJ; Ko MK; Lee BR
Cutan Ocul Toxicol; 2012 Jun; 31(2):144-7. PubMed ID: 22050195
[TBL] [Abstract][Full Text] [Related]
2. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
3. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
4. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
5. Retinal fluorescein and indocyanine green angiography and spectral-domain optical coherence tomography findings in acute retinal pigment epitheliitis.
Baillif S; Wolff B; Paoli V; Gastaud P; Mauget-Faÿsse M
Retina; 2011 Jun; 31(6):1156-63. PubMed ID: 21293312
[TBL] [Abstract][Full Text] [Related]
6. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
Kahn JB; Haberman ID; Reddy S
Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
[TBL] [Abstract][Full Text] [Related]
7. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
Pham BH; Marmor MF
Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
[TBL] [Abstract][Full Text] [Related]
8. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
Bhavsar KV; Mukkamala LK; Freund KB
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
[TBL] [Abstract][Full Text] [Related]
9. Angiographic analysis of retinal-choroidal anastomosis by confocal scanning laser ophthalmoscopy technology and corresponding (eye-tracked) spectral-domain optical coherence tomography.
Querques G; Atmani K; Berboucha E; Martinelli D; Coscas G; Soubrane G; Souied EH
Retina; 2010 Feb; 30(2):222-34. PubMed ID: 19952987
[TBL] [Abstract][Full Text] [Related]
10. Unilateral retinal pigment epithelium dysgenesis.
Cohen SY; Fung AE; Tadayoni R; Massin P; Barbazetto I; Berthout A; Gayet P; Meunier I; Yannuzzi LA
Am J Ophthalmol; 2009 Dec; 148(6):914-9.e2. PubMed ID: 19733831
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine retinopathy after short-term therapy.
Phillips BN; Chun DW
Retin Cases Brief Rep; 2014; 8(1):67-9. PubMed ID: 25372212
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine toxicity despite normal dose therapy.
Falcone PM; Paolini L; Lou PL
Ann Ophthalmol; 1993 Oct; 25(10):385-8. PubMed ID: 8304691
[TBL] [Abstract][Full Text] [Related]
13. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy.
Framme C; Walter A; Gabler B; Roider J; Sachs HG; Gabel VP
Acta Ophthalmol Scand; 2005 Apr; 83(2):161-7. PubMed ID: 15799726
[TBL] [Abstract][Full Text] [Related]
14. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
15. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
[TBL] [Abstract][Full Text] [Related]
16. Retinal pigment epithelial tear involving the fovea with preserved visual function.
Yoshitani S; Katsura M; Minamoto A; Tsumura K; Tamura H; Hasebe H; Mishima HK
Ophthalmic Surg Lasers Imaging; 2003; 34(3):217-20. PubMed ID: 12757098
[TBL] [Abstract][Full Text] [Related]
17. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
[TBL] [Abstract][Full Text] [Related]
18. The blood-retinal barrier in chloroquine retinopathy.
Raines MF; Bhargava SK; Rosen ES
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
[TBL] [Abstract][Full Text] [Related]
19. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
20. Bilateral choroidopathy in systemic lupus erythematosus.
Edouard S; Douat J; Sailler L; Arlet P; Astudillo L
Lupus; 2011 Oct; 20(11):1209-10. PubMed ID: 21511760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
